Using hydroxychloroquine and protecting the retina

Abstract

Get full access to this article

View all access options for this article.

References

Hartman

Kovanen

Lehtonen

Eklund

Sinisalo

. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: Rationale and design of the OXI trial. Eur Heart J Cardiovasc Pharmacother 2017; 3: 92–97.

Alarcón

McGwin

Bertoli

et al.

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 2007; 66: 1168–1172.

Tang

Godfrey

Stawell

Nikpour

. Hydroxychloroquine in lupus: Emerging evidence supporting multiple beneficial effects. Intern Med J 2012; 42: 968–978.

Costedoat-Chalumeau

Dunogué

Morel

Le Guern

Guettrot-Imbert

. Hydroxychloroquine: A multifaceted treatment in lupus. Presse Med 2014; 43(6 Pt 2): e167–e180.

Cairoli

Rebella

Danese

Garra

Borba

. Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: A longitudinal evaluation of the lipid-lowering effect. Lupus 2012; 21: 1178–1182.

Chen

Lin

Lan

et al.

Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: A population-based cohort study. Rheumatology (Oxford) 2015; 54: 1244–1249.

National Archives, http://content.digital.nhs.uk/catalogue/PUB23631/pres-cost-anal-eng-2016-trend.zip (accessed 14 May 2017).

Hunt

. A novel antiphospholipid antibody agent? Blood 2010; 115: 2124–2125.

Mekinian

Lazzaroni

Kuzenko

et al.

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. Autoimmun Rev 2015; 14: 498–502.

10.

Sciascia

Hunt

Talavera-Garcia

Lliso

Khamashta

Cuadrado

. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol 2016; 214: 273.e1–e273.8.

11.

Schmidt-Tanguy

Voswinkel

Henrion

et al.

Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 2013; 11: 1927–1929.

12.

Leroux

Desveaux

Parcevaux

et al.

Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: A descriptive cohort study. Lupus 2015; 24: 1384–1391.

13.

Ledingham

Gullick

Irving

et al.

BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) 2017; 56: 865–868.

14.

Parke

. Antimalarial drugs, systemic lupus erythematosus and pregnancy. J Rheumatol 1988; 15: 607–610.

15.

Parke

. Antimalarial drugs and pregnancy. Am J Med 1988; 85: 30–33.

16.

Østensen

Khamashta

Lockshin

et al.

Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8: 209–209.

17.

Flint

Panchal

Hurrell

et al.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding – Part I: Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 2016; 55: 1693–1697.

18.

Andreoli

Bertsias

Agmon-Levin

et al.

EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017; 76: 476–485.

19.

Rosenthal

Kolb

Bergsma

Huxsoll

Hopkins

. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978; 17: 1158–1175.

20.

Ding

Denniston

Rao

Gordon

. Hydroxychloroquine-related retinal toxicity. Rheumatology (Oxford) 2016; 55: 957–967.

21.

Sundelin

Terman

. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 2002; 110: 481–489.

22.

Marmor

Melles

. Hydroxychloroquine and the retina. JAMA 2015; 313: 847–848.

23.

Marmor

Kellner

Lai

et al.

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology 2016; 123: 1386–1394.

24.

Tsang

Ahmadi Pirshahid

Virgili

Gottlieb

Hamilton

Coupland

. Hydroxychloroquine and chloroquine retinopathy: A systematic review evaluating the multifocal electroretinogram as a screening test. Ophthalmology 2015; 122: 1239–1251.e4.

25.

Melles

Marmor

. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 2014; 132: 1453–1460.

26.

Royal College of Ophthalmologists. Hydroxychloroquine and chloroquine retinopathy, https://www.rcophth.ac.uk/standards-publications-research/clinical-guidelines/ (accessed 2017).